58. Vargas, R.A.; Soto-Aguilera, S.; Parra, M.; Herrera, S.; Santibañez, A.; Kossack, C.; Saavedra, C.P.; Mora, O.; Pineda, M.; Gonzalez, O.; et al. Analysis of microbiota-host communication mediated by butyrate in Atlantic salmon. *Comput. Struct. Biotechnol. J.* **2023**, *21*, 2558–2578. [CrossRef]

59. Nimalan, N.; Sørensen, S.L.; Fečkaninová, A.; Koščová, J.; Mudroňová, D.; Gancarčíková, S.; Vatsos, I.N.; Bisa, S.; Kiron, V.; Sørensen, M. Mucosal barrier status in Atlantic salmon fed marine or plant-based diets supplemented with probiotics. *Aquaculture* **2022**, *547*, 737516. [CrossRef]

60. Jalili, M.; Gerdol, M.; Greco, S.; Pallavicini, A.; Buonocore, F.; Scapigliati, G.; Picchietti, S.; Esteban, M.A.; Rye, M.; Bones, A. Differential Effects of Dietary Supplementation of Krill Meal, Soybean Meal, Butyrate, and Bactocell® on the Gene Expression of Atlantic Salmon Head Kidney. *Int. J. Mol. Sci.* **2020**, *21*, 886. [CrossRef]

61. Nicolas, G.R.; Chang, P.V. Deciphering the Chemical Lexicon of Host-Gut Microbiota Interactions. *Trends Pharmacol. Sci.* **2019**, *40*, 430–445. [CrossRef]

62. Roager, H.M.; Licht, T.R. Microbial tryptophan catabolites in health and disease. *Nat. Commun.* **2018**, *9*, 3294. [CrossRef]

63. Cervantes-Barragan, L.; Chai, J.N.; Tianero, M.D.; Di Luccia, B.; Ahern, P.P.; Merriman, J.; Cortez, V.S.; Caparon, M.G.; Donia, M.S.; Gilfillan, S.; et al. *Lactobacillus reuteri* induces gut intraepithelial CD4+CD8αα+T cells. *Science* **2017**, *357*, 806–810. [CrossRef] [PubMed]

64. Krishnan, S.; Ding, Y.; Saedi, N.; Choi, M.; Sridharan, G.V.; Sherr, D.H.; Yarmush, M.L.; Alaniz, R.C.; Jayaraman, A.; Lee, K. Gut Microbiota-Derived Tryptophan Metabolites Modulate Inflammatory Response in Hepatocytes and Macrophages. *Cell Rep.* **2018**, *23*, 1099–1111. [CrossRef] [PubMed]

65. Zelante, T.; Iannitti, R.G.; Cunha, C.; De Luca, A.; Giovannini, G.; Pieraccini, G.; Zecchi, R.; D'Angelo, C.; Massi-Benedetti, C.; Fallarino, F.; et al. Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22. *Immunity* **2013**, *39*, 372–385. [CrossRef]

66. Rothhammer, V.; Mascanfroni, I.D.; Bunse, L.; Takenaka, M.C.; Kenison, J.E.; Mayo, L.; Chao, C.-C.; Patel, B.; Yan, R.; Blain, M.; et al. Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor. *Nat. Med.* **2016**, *22*, 586–597. [CrossRef] [PubMed]

67. Fallarino, F.; Grohmann, U.; Vacca, C.; Orabona, C.; Spreca, A.; Fioretti, M.C.; Puccetti, P. T cell apoptosis by kynurenines. In *Proceedings of the Advances in Experimental Medicine and Biology. Adv. Exp. Med. Biol.* **2003**, *527*, 183–190. [PubMed]

68. Hoseini, S.M.; Pérez-Jiménez, A.; Costas, B.; Azeredo, R.; Gesto, M. Physiological roles of tryptophan in teleosts: Current knowledge and perspectives for future studies. *Rev. Aquac.* **2019**, *11*, 3–24. [CrossRef]

69. Khan, S.K.; Salin, K.R.; Yakupitiyage, A.; Tsusaka, T.W.; Nguyen, L.T.; Siddique, M.A.M. L-Tryptophan Mitigates Cannibalism and Improves Growth of Asian seabass, *Lates calcarifer* Reared in a RAS System. *Aquac. J.* **2023**, *3*, 168–180. [CrossRef]

70. Oyarzún-Salazar, R.; Muñoz, J.; Mardones, O.; Labbé, B.; Romero, A.; Nualart, D.; Vargas-Chacoff, L. Dietary melatonin and L-tryptophan supplementation counteracts the effects of acute stress in *Salmo salar*. *Aquaculture* **2022**, *550*, 737882. [CrossRef]

71. Yambe, H.; Kitamura, S.; Kamio, M.; Yamada, M.; Matsunaga, S.; Fusetani, N.; Yamazaki, F. I-Kynurenine, an amino acid identified as a sex pheromone in the urine of ovulated female masu salmon. *Proc. Natl. Acad. Sci. USA* **2006**, *103*, 15370–15374. [CrossRef]

72. Dhanasiri, A.K.S.; Jaramillo-Torres, A.; Chikwati, E.M.; Forberg, T.; Krogdahl, T.; Kortner, T.M. Effects of dietary supplementation with prebiotics and *Pediococcus acidilactici* on gut health, transcriptome, microbiota, and metabolome in Atlantic salmon (*Salmo salar* L.) after seawater transfer. *Anim. Microbiome* **2023**, *5*, 10. [CrossRef]

73. Asano, Y.; Hiramoto, T.; Nishino, R.; Aiba, Y.; Kimura, T.; Yoshihara, K.; Koga, Y.; Sudo, N. Critical role of gut microbiota in the production of biologically active, free catecholamines in the gut lumen of mice. *Am. J. Physiol. Liver Physiol.* **2012**, *303*, G1288–G1295. [CrossRef] [PubMed]

74. Oleskin, A.V.; El'-Registan, G.I.; Shenderov, B.A. Role of neuromediators in the functioning of the human microbiota: "Business talks" among microorganisms and the microbiota-host dialogue. *Microbiology* **2016**, *85*, 1–22. [CrossRef]

75. Nasi, G.; Ahmed, T.; Rasini, E.; Fenoglio, D.; Marino, F.; Filaci, G.; Cosentino, M. Dopamine inhibits human CD8+ Treg function through D1-like dopaminergic receptors. *J. Neuroimmunol.* **2019**, *332*, 233–241. [CrossRef] [PubMed]

76. Nakano, K.; Higashi, T.; Takagi, R.; Hashimoto, K.; Tanaka, Y.; Matsushita, S. Dopamine released by dendritic cells polarizes Th2 differentiation. *Int. Immunol.* **2009**, *21*, 645–654. [CrossRef] [PubMed]

77. Scanzano, A.; Cosentino, M. Adrenergic regulation of innate immunity: A review. *Front. Pharmacol.* **2015**, *6*, 171. [CrossRef] [PubMed]

78. Wan, M.; Ding, L.; Wang, D.; Han, J.; Gao, P. Serotonin: A Potent Immune Cell Modulator in Autoimmune Diseases. *Front. Immunol.* **2020**, *11*, 186. [CrossRef] [PubMed]

79. Yano, J.M.; Yu, K.; Donaldson, G.P.; Shastri, G.G.; Ann, P.; Ma, L.; Nagler, C.R.; Ismagilov, R.F.; Mazmanian, S.K.; Hsiao, E.Y. Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. *Cell* **2015**, *161*, 264–276, Erratum in *Cell* **2015**, *163*, 258. [CrossRef]

80. Auteri, M.; Zizzo, M.G.; Serio, R. GABA and GABA receptors in the gastrointestinal tract: From motility to inflammation. *Pharmacol. Res.* **2015**, *93*, 11–21. [CrossRef]

81. Fujii, T.; Mashimo, M.; Moriwaki, Y.; Misawa, H.; Ono, S.; Horiguchi, K.; Kawashima, K. Physiological functions of the cholinergic system in immune cells. *J. Pharmacol. Sci.* **2017**, *134*, 1–21. [CrossRef]
82. Branco, A.C.C.C.; Yoshikawa, F.S.Y.; Pietrobon, A.J.; Sato, M.N. Role of Histamine in Modulating the Immune Response and Inflammation. *Mediat. Inflamm.* **2018**, *2018*, 9524075. [CrossRef]

83. Muñoz, J.; Ocampos, D.; Poblete-Morales, M.; Oyarzún, R.; Morera, F.; Tapia-Cammas, D.; Avendaño-Herrera, R.; Vargas-Chacoff, L. Effect of *Flavobacterium psychrophilum* on the neuroendocrine response of rainbow trout (*Oncorhynchus mykiss*) in a time course experiment. *Comp. Biochem. Physiol. Part A: Mol. Integr. Physiol.* **2019**, *236*, 110525. [CrossRef] [PubMed]

84. Ferriere, F.; Khan, N.; Troutaud, D.; Deschaux, P. Serotonin modulation of lymphocyte proliferation via 5-HT1A receptors in rainbow trout (*Oncorhynchus mykiss*). *Dev. Comp. Immunol.* **1996**, *20*, 273-283. [CrossRef]

85. Torrealba, D.; Balasch, J.C.; Criado, M.; Tort, L.; Mackenzie, S.; Roher, N. Functional evidence for the inflammatory reflex in teleosts: A novel α7 nicotinic acetylcholine receptor modulates the macrophage response to dsRNA. *Dev. Comp. Immunol.* **2018**, *84*, 279-291. [CrossRef] [PubMed]

86. Reyneveld, G.I.; Savelkoul, H.F.J.; Parmentier, H.K. Current Understanding of Natural Antibodies and Exploring the Possibilities of Modulation Using Veterinary Models. A Review. *Front. Immunol.* **2020**, *11*, 2139. [CrossRef] [PubMed]

87. Holodick, N.E.; Rodríguez-Zhurbenko, N.; Hernández, A.M. Defining Natural Antibodies. *Front. Immunol.* **2017**, *8*, 872. [CrossRef] [PubMed]

88. Parmentier, H.K.; Lammers, A.; Hoekman, J.J.; Reilingh, G.D.V.; Zaanen, I.T.A.; Savelkoul, H.F.J. Different levels of natural antibodies in chickens divergently selected for specific antibody responses. *Dev. Comp. Immunol.* **2004**, *28*, 39-49. [CrossRef] [PubMed]

89. Matson, K.D.; Ricklefs, R.E.; Klasing, K.C. A hemolysis-hemagglutination assay for characterizing constitutive innate humoral immunity in wild and domestic birds. *Dev. Comp. Immunol.* **2005**, *29*, 275-286. [CrossRef] [PubMed]

90. Ujvari, B.; Madsen, T. Do natural antibodies compensate for humoral immunosenescence in tropical pythons? *Funct. Ecol.* **2011**, *25*, 813-817. [CrossRef]

91. Magnadottir, B.; Gudmundsdottir, S.; Gudmundsdottir, B.K.; Helgason, S. Natural antibodies of cod (*Gadus morhua* L.): Specificity, activity and affinity. *Comp. Biochem. Physiol. B Biochem. Mol. Biol.* **2009**, *154*, 309-316. [CrossRef]

92. Gonzalez, R.; Charlemagne, J.; Mahana, W.; Avrameas, S. Specificity of natural serum antibodies present in phylogenetically distinct fish species. *Immunology* **1988**, *63*, 31.

93. Grönwall, C.; Silverman, G.J. Natural IgM: Beneficial autoantibodies for the control of inflammatory and autoimmune disease. *J. Clin. Immunol.* **2014**, *34* (Suppl. 1), 12-21. [CrossRef] [PubMed]

94. Zorn, E.; See, S.B. Is there a role for natural antibodies in rejection following transplantation? *Transplantation* **2019**, *103*, 1612. [CrossRef] [PubMed]

95. Chen, Y.; Park, Y.-B.; Patel, E.; Silverman, G.J. IgM Antibodies to apoptosis-associated determinants recruit C1q and enhance dendritic cell phagocytosis of apoptotic cells. *J. Immunol.* **2009**, *182*, 6031-6043. [CrossRef] [PubMed]

96. Panda, S.; Zhang, J.; Tan, N.S.; Ho, B.; Ding, J.L. Natural IgG antibodies provide innate protection against ficolin-opsonized bacteria. *EMBO J.* **2013**, *32*, 2905-2919. [CrossRef] [PubMed]

97. Zhou, Z.-H.; Wild, T.; Xiong, Y.; Sylvers, L.H.; Zhang, Y.; Zhang, L.; Wahl, L.; Wahl, S.M.; Kozlowski, S.; Notkins, A.L. Polyreactive antibodies plus complement enhance the phagocytosis of cells made apoptotic by UV-light or HIV. *Sci. Rep.* **2013**, *3*, 2271. [CrossRef] [PubMed]

98. Wijga, S.; Bovenhuis, H.; Bastiaansen, J.W.M.; van Arendonk, J.A.M.; Ploegaert, T.C.W.; Tijhaar, E.; van der Poel, J.J. Genetic parameters for natural antibody isotype titers in milk of Dutch Holstein-Friesians. *Anim. Genet.* **2013**, *44*, 485-492. [CrossRef]

99. Bello-Gil, D.; Audebert, C.; Olivera-Ardid, S.; Pérez-Cruz, M.; Even, G.; Khasbiullina, N.; Gantois, N.; Shilova, N.; Merlin, S.; Costa, C.; et al. The Formation of Glycan-Specific Natural Antibodies Repertoire in GalT-KO Mice Is Determined by Gut Microbiota. *Front. Immunol.* **2019**, *10*, 342. [CrossRef]

100. Hodžić, A.; Mateos-Hernández, L.; de la Fuente, J.; Cabezas-Cruz, A. α-Gal-Based Vaccines: Advances, Opportunities, and Perspectives. *Trends Parasitol.* **2020**, *36*, 992-1001. [CrossRef]

101. Almeida, I.C.; Milani, S.R.; A Gorin, P.; Travassos, L.R. Complement-mediated lysis of *Trypanosoma cruzi* trypomastigotes by human anti-alpha-galactosyl antibodies. *J. Immunol.* **1991**, *146*, 2394-2400. [CrossRef]

102. Al-Salem, W.S.; Ferreira, D.M.; Dyer, N.A.; Alyamani, E.J.; Balghonaim, S.M.; Al-Mehna, A.Y.; Al-Zubiany, S.; Ibrahim, E.-K.; AL Shahrani, A.M.; Alkhuailed, H.; et al. Detection of high levels of anti-α-galactosyl antibodies in sera of patients with Old World cutaneous leishmaniasis: A possible tool for diagnosis and biomarker for cure in an elimination setting. *Parasitology* **2014**, *141*, 1898-1903. [CrossRef]

103. Cabezas-Cruz, A.; Mateos-Hernández, L.; Alberdi, P.; Villar, M.; Riveau, G.; Hermann, E.; Schacht, A.-M.; Khalife, J.; Correia-Neves, M.; Gortazar, C.; et al. Effect of blood type on anti-α-Gal immunity and the incidence of infectious diseases. *Exp. Mol. Med.* **2017**, *49*, e301. [CrossRef]

104. Yilmaz, B.; Portugal, S.; Tran, T.M.; Gozzelino, R.; Ramos, S.; Gomes, J.; Regalado, A.; Cowan, P.J.; D'apice, A.J.; Chong, A.S.; et al. Gut microbiota elicits a protective immune response against malaria transmission. *Cell* **2014**, *159*, 1277-1289. [CrossRef] [PubMed]

105. Mateos-Hernández, L.; Risco-Castillo, V.; Torres-Maravilla, E.; Bermúdez-Humarán, L.G.; Alberdi, P.; Hodžić, A.; Hernández-Jarguin, A.; Rakotobe, S.; Galon, C.; Devillers, E.; et al. Gut Microbiota Abrogates Anti-α-Gal IgA Response in Lungs and Protects against Experimental *Aspergillus* Infection in Poultry. *Vaccines* **2020**, *8*, 285. [CrossRef]
82. Branco, A.C.C.C.; Yoshikawa, F.S.Y.; Pietrobon, A.J.; Sato, M.N. Role of Histamine in Modulating the Immune Response and Inflammation. *Mediat. Inflamm.* **2018**, *2018*, 9524075. [CrossRef]

83. Muñoz, J.; Ocampos, D.; Poblete-Morales, M.; Oyarzún, R.; Morera, F.; Tapia-Cammas, D.; Avendaño-Herrera, R.; Vargas-Chacoff, L. Effect of *Flavobacterium psychrophilum* on the neuroendocrine response of rainbow trout (*Oncorhynchus mykiss*) in a time course experiment. *Comp. Biochem. Physiol. Part A: Mol. Integr. Physiol.* **2019**, *236*, 110525. [CrossRef] [PubMed]

84. Ferriere, F.; Khan, N.; Troutaud, D.; Deschaux, P. Serotonin modulation of lymphocyte proliferation via 5-HT1A receptors in rainbow trout (*Oncorhynchus mykiss*). *Dev. Comp. Immunol.* **1996**, *20*, 273-283. [CrossRef]

85. Torrealba, D.; Balasch, J.C.; Criado, M.; Tort, L.; Mackenzie, S.; Roher, N. Functional evidence for the inflammatory reflex in teleosts: A novel α7 nicotinic acetylcholine receptor modulates the macrophage response to dsRNA. *Dev. Comp. Immunol.* **2018**, *84*, 279-291. [CrossRef] [PubMed]

86. Reyneveld, G.I.; Savelkoul, H.F.J.; Parmentier, H.K. Current Understanding of Natural Antibodies and Exploring the Possibilities of Modulation Using Veterinary Models. A Review. *Front. Immunol.* **2020**, *11*, 2139. [CrossRef] [PubMed]

87. Holodick, N.E.; Rodríguez-Zhurbenko, N.; Hernández, A.M. Defining Natural Antibodies. *Front. Immunol.* **2017**, *8*, 872. [CrossRef] [PubMed]

88. Parmentier, H.K.; Lammers, A.; Hoekman, J.J.; Reilingh, G.D.V.; Zaanen, I.T.A.; Savelkoul, H.F.J. Different levels of natural antibodies in chickens divergently selected for specific antibody responses. *Dev. Comp. Immunol.* **2004**, *28*, 39-49. [CrossRef] [PubMed]

89. Matson, K.D.; Ricklefs, R.E.; Klasing, K.C. A hemolysis-hemagglutination assay for characterizing constitutive innate humoral immunity in wild and domestic birds. *Dev. Comp. Immunol.* **2005**, *29*, 275-286. [CrossRef] [PubMed]

90. Ujvari, B.; Madsen, T. Do natural antibodies compensate for humoral immunosenescence in tropical pythons? *Funct. Ecol.* **2011**, *25*, 813-817. [CrossRef]

91. Magnadottir, B.; Gudmundsdottir, S.; Gudmundsdottir, B.K.; Helgason, S. Natural antibodies of cod (*Gadus morhua* L.): Specificity, activity and affinity. *Comp. Biochem. Physiol. B Biochem. Mol. Biol.* **2009**, *154*, 309-316. [CrossRef]

92. Gonzalez, R.; Charlemagne, J.; Mahana, W.; Avrameas, S. Specificity of natural serum antibodies present in phylogenetically distinct fish species. *Immunology* **1988**, *63*, 31.

93. Grönwall, C.; Silverman, G.J. Natural IgM: Beneficial autoantibodies for the control of inflammatory and autoimmune disease. *J. Clin. Immunol.* **2014**, *34* (Suppl. 1), 12-21. [CrossRef] [PubMed]

94. Zorn, E.; See, S.B. Is there a role for natural antibodies in rejection following transplantation? *Transplantation* **2019**, *103*, 1612. [CrossRef] [PubMed]

95. Chen, Y.; Park, Y.-B.; Patel, E.; Silverman, G.J. IgM Antibodies to apoptosis-associated determinants recruit C1q and enhance dendritic cell phagocytosis of apoptotic cells. *J. Immunol.* **2009**, *182*, 6031-6043. [CrossRef] [PubMed]

96. Panda, S.; Zhang, J.; Tan, N.S.; Ho, B.; Ding, J.L. Natural IgG antibodies provide innate protection against ficolin-opsonized bacteria. *EMBO J.* **2013**, *32*, 2905-2919. [CrossRef] [PubMed]

97. Zhou, Z.-H.; Wild, T.; Xiong, Y.; Sylvers, L.H.; Zhang, Y.; Zhang, L.; Wahl, L.; Wahl, S.M.; Kozlowski, S.; Notkins, A.L. Polyreactive antibodies plus complement enhance the phagocytosis of cells made apoptotic by UV-light or HIV. *Sci. Rep.* **2013**, *3*, 2271. [CrossRef] [PubMed]

98. Wijga, S.; Bovenhuis, H.; Bastiaansen, J.W.M.; van Arendonk, J.A.M.; Ploegaert, T.C.W.; Tijhaar, E.; van der Poel, J.J. Genetic parameters for natural antibody isotype titers in milk of Dutch Holstein-Friesians. *Anim. Genet.* **2013**, *44*, 485-492. [CrossRef]

99. Bello-Gil, D.; Audebert, C.; Olivera-Ardid, S.; Pérez-Cruz, M.; Even, G.; Khasbiullina, N.; Gantois, N.; Shilova, N.; Merlin, S.; Costa, C.; et al. The Formation of Glycan-Specific Natural Antibodies Repertoire in GalT-KO Mice Is Determined by Gut Microbiota. *Front. Immunol.* **2019**, *10*, 342. [CrossRef]

100. Hodžić, A.; Mateos-Hernández, L.; de la Fuente, J.; Cabezas-Cruz, A. α-Gal-Based Vaccines: Advances, Opportunities, and Perspectives. *Trends Parasitol.* **2020**, *36*, 992-1001. [CrossRef]

101. Almeida, I.C.; Milani, S.R.; A Gorin, P.; Travassos, L.R. Complement-mediated lysis of *Trypanosoma cruzi* trypomastigotes by human anti-alpha-galactosyl antibodies. *J. Immunol.* **1991**, *146*, 2394-2400. [CrossRef]

102. Al-Salem, W.S.; Ferreira, D.M.; Dyer, N.A.; Alyamani, E.J.; Balghonaim, S.M.; Al-Mehna, A.Y.; Al-Zubiany, S.; Ibrahim, E.-K.; AL Shahrani, A.M.; Alkhuailed, H.; et al. Detection of high levels of anti-α-galactosyl antibodies in sera of patients with Old World cutaneous leishmaniasis: A possible tool for diagnosis and biomarker for cure in an elimination setting. *Parasitology* **2014**, *141*, 1898-1903. [CrossRef]

103. Cabezas-Cruz, A.; Mateos-Hernández, L.; Alberdi, P.; Villar, M.; Riveau, G.; Hermann, E.; Schacht, A.-M.; Khalife, J.; Correia-Neves, M.; Gortazar, C.; et al. Effect of blood type on anti-α-Gal immunity and the incidence of infectious diseases. *Exp. Mol. Med.* **2017**, *49*, e301. [CrossRef]

104. Yilmaz, B.; Portugal, S.; Tran, T.M.; Gozzelino, R.; Ramos, S.; Gomes, J.; Regalado, A.; Cowan, P.J.; D'apice, A.J.; Chong, A.S.; et al. Gut microbiota elicits a protective immune response against malaria transmission. *Cell* **2014**, *159*, 1277-1289. [CrossRef] [PubMed]

105. Mateos-Hernández, L.; Risco-Castillo, V.; Torres-Maravilla, E.; Bermúdez-Humarán, L.G.; Alberdi, P.; Hodžić, A.; Hernández-Jarguin, A.; Rakotobe, S.; Galon, C.; Devillers, E.; et al. Gut Microbiota Abrogates Anti-α-Gal IgA Response in Lungs and Protects against Experimental *Aspergillus* Infection in Poultry. *Vaccines* **2020**, *8*, 285. [CrossRef]
106. Pacheco, I.; Contreras, M.; Villar, M.; Risalde, M.A.; Alberdi, P.; Cabezas-Cruz, A.; Gortázar, C.; de la Fuente, J. Vaccination with Alpha-Gal Protects Against Mycobacterial Infection in the Zebrafish Model of Tuberculosis. *Vaccines* **2020**, *8*, 195. [CrossRef] [PubMed]

107. Pacheco, I.; Díaz-Sánchez, S.; Contreras, M.; Villar, M.; Cabezas-Cruz, A.; Gortázar, C.; de la Fuente, J. Probiotic bacteria with high alpha-gal content protect zebrafish against Mycobacteriosis. *Pharmaceuticals* **2021**, *14*, 635. [CrossRef] [PubMed]

108. Galili, U. Anti-Gal: An abundant human natural antibody of multiple pathogeneses and clinical benefits. *Immunology* **2013**, *140*, 1-11. [CrossRef] [PubMed]

109. Singh, S.; Bastos-Amador, P.; Thompson, J.A.; Truglio, M.; Yilmaz, B.; Cardoso, S.; Sobral, D.; Soares, M.P. Glycan-based shaping of the microbiota during primate evolution. *eLife* **2021**, *10*. [CrossRef] [PubMed]

110. Jesus, L.C.L.d; Lima, F.A.; Coelho-Rocha, N.D.; Silva, T.F.d; Paz, J.; Azevedo, V.; Mancha-Agesti, P.; Drumond, M.M. Recombinant Probiotics and Microbiota Modulation as a Good Therapy for Diseases Related to the GIT. In *The Health Benefits of Foods-Current Knowledge and Further Development*; IntechOpen: London, UK, 2019. [CrossRef]

111. Ou, B.; Yang, Y.; Tham, W.L.; Chen, L.; Guo, J.; Zhu, G. Genetic engineering of probiotic *Escherichia coli* Nissle 1917 for clinical application. *Appl. Microbiol. Biotechnol.* **2016**, *100*, 8693-8699. [CrossRef]

112. Michon, C.; Langella, P.; Eijsink, V.G.H.; Mathiesen, G.; Chatel, J.M. Display of recombinant proteins at the surface of lactic acid bacteria: Strategies and applications. *Microb. Cell Factories* **2016**, *15*, 70. [CrossRef]

113. Shigemori, S.; Shimosato, T. Applications of genetically modified immunobiotics with high immunoregulatory capacity for treatment of inflammatory bowel diseases. *Front. Immunol.* **2017**, *8*, 22. [CrossRef]

114. Vilander, A.C.; Dean, G.A. Adjuvant strategies for lactic acid bacterial mucosal vaccines. *Vaccines* **2019**, *7*, 150. [CrossRef] [PubMed]

115. A Börner, R.; Kandasamy, V.; Axelsen, A.M.; Nielsen, A.T.; Bosma, E.F. Genome editing of lactic acid bacteria: Opportunities for food, feed, pharma and biotech. *FEMS Microbiol. Lett.* **2019**, *366*, fny291. [CrossRef] [PubMed]

116. Lv, P.; Song, Y.; Liu, C.; Yu, L.; Shang, Y.; Tang, H.; Sun, S.; Wang, F. Application of *Bacillus subtilis* as a live vaccine vector: A review. *J. Veter.-Med. Sci.* **2020**, *82*, 1693-1699. [CrossRef] [PubMed]

117. Kang, M.; Choe, D.; Kim, K.; Cho, B.-K.; Cho, S. Synthetic Biology Approaches in the Development of Engineered Therapeutic Microbes. *Int. J. Mol. Sci.* **2020**, *21*, 8744. [CrossRef] [PubMed]

118. Tavares, L.M.; de Jesus, L.C.L.; da Silva, T.F.; Barroso, F.A.L.; Batista, V.L.; Coelho-Rocha, N.D.; Azevedo, V.; Drumond, M.M.; Mancha-Agesti, P. Novel Strategies for Efficient Production and Delivery of Live Biotherapeutics and Biotechnological Uses of *Lactococcus lactis*: The Lactic Acid Bacterium Model. *Front. Bioeng. Biotechnol.* **2020**, *8*, 517166. [CrossRef] [PubMed]

119. Wang, D.; Liu, Q.; Jiang, Y.-L.; Huang, H.-B.; Li, J.-Y.; Pan, T.-X.; Wang, N.; Yang, W.-T.; Cao, X.; Zeng, Y.; et al. Oral immunization with recombinant *Lactobacillus plantarum* expressing Nudix hydrolase and 43 kDa proteins confers protection against *Trichinella spiralis* in BALB/c mice. *Acta Trop.* **2021**, *220*, 105947. [CrossRef]

120. Diaz-Dinamarca, D.A.; Hernandez, C.; Escobar, D.F.; Soto, D.A.; Muñoz, G.A.; Badilla, J.F.; Manzo, R.A.; Carrión, F.; Kalergis, A.M.; Vasquez, A.E. Mucosal Vaccination with *Lactococcus lactis*-Secreting Surface Immunological Protein Induces Humoral and Cellular Immune Protection against Group B *Streptococcus* in a Murine Model. *Vaccines* **2020**, *8*, 146. [CrossRef] [PubMed]

121. Yang, W.-T.; Shi, S.-H.; Yang, G.-L.; Jiang, Y.-L.; Zhao, L.; Li, Y.; Wang, C.-F. Cross-protective efficacy of dendritic cells targeting conserved influenza virus antigen expressed by *Lactobacillus plantarum*. *Sci. Rep.* **2016**, *6*, 39665. [CrossRef]

122. Carvalho, R.D.D.O.; Carmo, F.L.R.D.; Junior, A.d.O.; Langella, P.; Chatel, J.-M.; Bermúdez-Humarán, L.G.; Azevedo, V.; de Azevedo, M.S. Use of Wild Type or Recombinant Lactic Acid Bacteria as an Alternative Treatment for Gastrointestinal Inflammatory Diseases: A Focus on Inflammatory Bowel Diseases and Mucositis. *Front. Microbiol.* **2017**, *8*, 800. [CrossRef]

123. Jacouton, E.; Maravilla, E.T.; Boucard, A.-S.; Pouderous, N.; Vilela, A.P.P.; Naas, I.; Chain, F.; Azevedo, V.; Langella, P.; Bermúdez-Humarán, L.G. Anti-tumoral Effects of Recombinant *Lactococcus lactis* Strain Secreting IL-17A Cytokine. *Front. Microbiol.* **2019**, *9*, 3355. [CrossRef]

124. Bermúdez-Humarán, L.G.; Langella, P. Live bacterial biotherapeutics in the clinic. *Nat. Biotechnol.* **2018**, *36*, 816–818. [CrossRef] [PubMed]

125. Min, L.; Li-Li, Z.; Jun-Wei, G.; Xin-Yuan, Q.; Yi-Jing, L.; Di-Qiu, L. Immunogenicity of *Lactobacillus*-expressing VP2 and VP3 of the infectious pancreatic necrosis virus (IPNV) in rainbow trout. *Fish Shellfish Immunol.* **2012**, *32*, 196–203. [CrossRef] [PubMed]

126. Li-Li, Z.; Min, L.; Jun-Wei, G.; Xin-Yuan, Q.; Yi-Jing, L.; Di-Qiu, L. Expression of infectious pancreatic necrosis virus (IPNV) VP2-VP3 fusion protein in *Lactobacillus casei* and immunogenicity in rainbow trouts. *Vaccine* **2012**, *30*, 1823–1829. [CrossRef] [PubMed]

127. Duan, K.; Hua, X.; Wang, Y.; Wang, Y.; Chen, Y.; Shi, W.; Tang, L.; Li, Y.; Liu, M. Oral immunization with a recombinant *Lactobacillus* expressing CK6 fused with VP2 protein against IPNV in rainbow trout (*Oncorhynchus mykiss*). *Fish Shellfish Immunol.* **2018**, *83*, 223–231. [CrossRef] [PubMed]

128. Chen, Y.; Hua, X.; Ren, X.; Duan, K.; Gao, S.; Sun, J.; Feng, Y.; Zhou, Y.; Guan, X.; Li, D.; et al. Oral immunization with recombinant *Lactobacillus casei* displayed AHA1-CK6 and VP2 induces protection against infectious pancreatic necrosis in rainbow trout (*Oncorhynchus mykiss*). *Fish Shellfish Immunol.* **2020**, *100*, 18–26. [CrossRef] [PubMed]

129. Hua, X.; Zhou, Y.; Feng, Y.; Duan, K.; Ren, X.; Sun, J.; Gao, S.; Wang, N.; Li, J.; Yang, J.; et al. Oral vaccine against IPNV based on antibiotic-free resistance recombinant *Lactobacillus casei* expressing CK6-VP2 fusion protein. *Aquaculture* **2021**, *535*, 736425. [CrossRef]
106. Pacheco, I.; Contreras, M.; Villar, M.; Risalde, M.A.; Alberdi, P.; Cabezas-Cruz, A.; Gortázar, C.; de la Fuente, J. Vaccination with Alpha-Gal Protects Against Mycobacterial Infection in the Zebrafish Model of Tuberculosis. *Vaccines* **2020**, *8*, 195. [CrossRef] [PubMed]

107. Pacheco, I.; Díaz-Sánchez, S.; Contreras, M.; Villar, M.; Cabezas-Cruz, A.; Gortázar, C.; de la Fuente, J. Probiotic bacteria with high alpha-gal content protect zebrafish against Mycobacteriosis. *Pharmaceuticals* **2021**, *14*, 635. [CrossRef] [PubMed]

108. Galili, U. Anti-Gal: An abundant human natural antibody of multiple pathogeneses and clinical benefits. *Immunology* **2013**, *140*, 1-11. [CrossRef] [PubMed]

109. Singh, S.; Bastos-Amador, P.; Thompson, J.A.; Truglio, M.; Yilmaz, B.; Cardoso, S.; Sobral, D.; Soares, M.P. Glycan-based shaping of the microbiota during primate evolution. *eLife* **2021**, *10*. [CrossRef] [PubMed]

110. Jesus, L.C.L.d; Lima, F.A.; Coelho-Rocha, N.D.; Silva, T.F.d; Paz, J.; Azevedo, V.; Mancha-Agesti, P.; Drumond, M.M. Recombinant Probiotics and Microbiota Modulation as a Good Therapy for Diseases Related to the GIT. In *The Health Benefits of Foods-Current Knowledge and Further Development*; IntechOpen: London, UK, 2019. [CrossRef]

111. Ou, B.; Yang, Y.; Tham, W.L.; Chen, L.; Guo, J.; Zhu, G. Genetic engineering of probiotic *Escherichia coli* Nissle 1917 for clinical application. *Appl. Microbiol. Biotechnol.* **2016**, *100*, 8693-8699. [CrossRef]

112. Michon, C.; Langella, P.; Eijsink, V.G.H.; Mathiesen, G.; Chatel, J.M. Display of recombinant proteins at the surface of lactic acid bacteria: Strategies and applications. *Microb. Cell Factories* **2016**, *15*, 70. [CrossRef]

113. Shigemori, S.; Shimosato, T. Applications of genetically modified immunobiotics with high immunoregulatory capacity for treatment of inflammatory bowel diseases. *Front. Immunol.* **2017**, *8*, 22. [CrossRef]

114. Vilander, A.C.; Dean, G.A. Adjuvant strategies for lactic acid bacterial mucosal vaccines. *Vaccines* **2019**, *7*, 150. [CrossRef] [PubMed]

115. A Börner, R.; Kandasamy, V.; Axelsen, A.M.; Nielsen, A.T.; Bosma, E.F. Genome editing of lactic acid bacteria: Opportunities for food, feed, pharma and biotech. *FEMS Microbiol. Lett.* **2019**, *366*, fny291. [CrossRef] [PubMed]

116. Lv, P.; Song, Y.; Liu, C.; Yu, L.; Shang, Y.; Tang, H.; Sun, S.; Wang, F. Application of *Bacillus subtilis* as a live vaccine vector: A review. *J. Veter.-Med. Sci.* **2020**, *82*, 1693-1699. [CrossRef] [PubMed]

117. Kang, M.; Choe, D.; Kim, K.; Cho, B.-K.; Cho, S. Synthetic Biology Approaches in the Development of Engineered Therapeutic Microbes. *Int. J. Mol. Sci.* **2020**, *21*, 8744. [CrossRef] [PubMed]

118. Tavares, L.M.; de Jesus, L.C.L.; da Silva, T.F.; Barroso, F.A.L.; Batista, V.L.; Coelho-Rocha, N.D.; Azevedo, V.; Drumond, M.M.; Mancha-Agesti, P. Novel Strategies for Efficient Production and Delivery of Live Biotherapeutics and Biotechnological Uses of *Lactococcus lactis*: The Lactic Acid Bacterium Model. *Front. Bioeng. Biotechnol.* **2020**, *8*, 517166. [CrossRef] [PubMed]

119. Wang, D.; Liu, Q.; Jiang, Y.-L.; Huang, H.-B.; Li, J.-Y.; Pan, T.-X.; Wang, N.; Yang, W.-T.; Cao, X.; Zeng, Y.; et al. Oral immunization with recombinant *Lactobacillus plantarum* expressing Nudix hydrolase and 43 kDa proteins confers protection against *Trichinella spiralis* in BALB/c mice. *Acta Trop.* **2021**, *220*, 105947. [CrossRef]

120. Diaz-Dinamarca, D.A.; Hernandez, C.; Escobar, D.F.; Soto, D.A.; Muñoz, G.A.; Badilla, J.F.; Manzo, R.A.; Carrión, F.; Kalergis, A.M.; Vasquez, A.E. Mucosal Vaccination with *Lactococcus lactis*-Secreting Surface Immunological Protein Induces Humoral and Cellular Immune Protection against Group B *Streptococcus* in a Murine Model. *Vaccines* **2020**, *8*, 146. [CrossRef] [PubMed]

121. Yang, W.-T.; Shi, S.-H.; Yang, G.-L.; Jiang, Y.-L.; Zhao, L.; Li, Y.; Wang, C.-F. Cross-protective efficacy of dendritic cells targeting conserved influenza virus antigen expressed by *Lactobacillus plantarum*. *Sci. Rep.* **2016**, *6*, 39665. [CrossRef]

122. Carvalho, R.D.D.O.; Carmo, F.L.R.D.; Junior, A.d.O.; Langella, P.; Chatel, J.-M.; Bermúdez-Humarán, L.G.; Azevedo, V.; de Azevedo, M.S. Use of Wild Type or Recombinant Lactic Acid Bacteria as an Alternative Treatment for Gastrointestinal Inflammatory Diseases: A Focus on Inflammatory Bowel Diseases and Mucositis. *Front. Microbiol.* **2017**, *8*, 800. [CrossRef]

123. Jacouton, E.; Maravilla, E.T.; Boucard, A.-S.; Pouderous, N.; Vilela, A.P.P.; Naas, I.; Chain, F.; Azevedo, V.; Langella, P.; Bermúdez-Humarán, L.G. Anti-tumoral Effects of Recombinant *Lactococcus lactis* Strain Secreting IL-17A Cytokine. *Front. Microbiol.* **2019**, *9*, 3355. [CrossRef]

124. Bermúdez-Humarán, L.G.; Langella, P. Live bacterial biotherapeutics in the clinic. *Nat. Biotechnol.* **2018**, *36*, 816-818. [CrossRef] [PubMed]

125. Min, L.; Li-Li, Z.; Jun-Wei, G.; Xin-Yuan, Q.; Yi-Jing, L.; Di-Qiu, L. Immunogenicity of *Lactobacillus*-expressing VP2 and VP3 of the infectious pancreatic necrosis virus (IPNV) in rainbow trout. *Fish Shellfish Immunol.* **2012**, *32*, 196-203. [CrossRef] [PubMed]

126. Li-Li, Z.; Min, L.; Jun-Wei, G.; Xin-Yuan, Q.; Yi-Jing, L.; Di-Qiu, L. Expression of infectious pancreatic necrosis virus (IPNV) VP2-VP3 fusion protein in *Lactobacillus casei* and immunogenicity in rainbow trouts. *Vaccine* **2012**, *30*, 1823-1829. [CrossRef] [PubMed]

127. Duan, K.; Hua, X.; Wang, Y.; Wang, Y.; Chen, Y.; Shi, W.; Tang, L.; Li, Y.; Liu, M. Oral immunization with a recombinant *Lactobacillus* expressing CK6 fused with VP2 protein against IPNV in rainbow trout (*Oncorhynchus mykiss*). *Fish Shellfish Immunol.* **2018**, *83*, 223-231. [CrossRef] [PubMed]

128. Chen, Y.; Hua, X.; Ren, X.; Duan, K.; Gao, S.; Sun, J.; Feng, Y.; Zhou, Y.; Guan, X.; Li, D.; et al. Oral immunization with recombinant *Lactobacillus casei* displayed AHA1-CK6 and VP2 induces protection against infectious pancreatic necrosis in rainbow trout (*Oncorhynchus mykiss*). *Fish Shellfish Immunol.* **2020**, *100*, 18-26. [CrossRef] [PubMed]

129. Hua, X.; Zhou, Y.; Feng, Y.; Duan, K.; Ren, X.; Sun, J.; Gao, S.; Wang, N.; Li, J.; Yang, J.; et al. Oral vaccine against IPNV based on antibiotic-free resistance recombinant *Lactobacillus casei* expressing CK6-VP2 fusion protein. *Aquaculture* **2021**, *535*, 736425. [CrossRef]
130. Naderi-Samani, M.; Soltani, M.; Dadar, M.; Taheri-Mirghaed, A.; Zargar, A.; Ahmadivand, S.; Hassanzadeh, R.; Goudarzi, L.M. Oral immunization of trout fry with recombinant *Lactococcus lactis* NZ3900 expressing G gene of viral hemorrhagic septicaemia virus (VHSV). *Fish Shellfish Immunol.* **2020**, *105*, 62–70. [CrossRef] [PubMed]

131. Zhao, L.; Tang, X.; Sheng, X.; Xing, J.; Zhan, W. Surface display of hirame novirhabdovirus (HIRRV) G protein in *Lactococcus lactis* and its immune protection in flounder (*Paralichthys olivaceus*). *Microb. Cell Factories* **2019**, *18*, 142. [CrossRef]

132. Zhang, L.; Li, Z.; Li, Y.; Tian, J.; Jia, K.; Zhang, D.; Song, M.; Raza, S.H.A.; Garcia, M.; Kang, Y.; et al. OmpW expressed by recombinant *Lactobacillus casei* elicits protective immunity against *Aeromonas veronii* in common carp. *Microb. Pathog.* **2019**, *133*, 103552–103559. [CrossRef]

133. Zhang, D.-X.; Kang, Y.-H.; Chen, L.; Siddiqui, S.A.; Wang, C.-F.; Qian, A.-D.; Shan, X.-F. Oral immunization with recombinant *Lactobacillus casei* expressing OmpAI confers protection against *Aeromonas veronii* challenge in common carp, *Cyprinus carpio*. *Fish Shellfish Immunol.* **2018**, *72*, 552–563. [CrossRef]

134. Chen, C.; Zu, S.; Zhang, D.; Zhao, Z.; Ji, Y.; Xi, H.; Shan, X.; Qian, A.; Han, W.; Gu, J. Oral vaccination with recombinant *Lactobacillus casei* expressing Aha1 fused with CTB as an adjuvant against *Aeromonas veronii* in common carp (*Cyprinus carpio*). *Microb. Cell Factories* **2022**, *21*, 114. [CrossRef] [PubMed]

135. Jiao, X.; Zhang, D.-X.; Chen, C.; Kong, L.-C.; Hu, X.-Y.; Shan, X.-F.; Qian, A.-D. Immunization effect of recombinant *Lactobacillus casei* displaying *Aeromonas veronii* Aha1 with an LTB adjuvant in carp. *Fish Shellfish Immunol.* **2023**, *135*, 108660. [CrossRef] [PubMed]

136. Zhao, Z.; Wang, H.; Zhang, D.; Guan, Y.; Siddiqui, S.A.; Feng-Shan, X.; Cong, B. Oral vaccination with recombinant *Lactobacillus casei* expressing *Aeromonas hydrophila* Aha1 against *A. hydrophila* infections in common carps. *Virulence* **2022**, *13*, 794–807. [CrossRef] [PubMed]

137. Jia, S.; Zhou, K.; Pan, R.; Wei, J.; Liu, Z.; Xu, Y. Oral immunization of carps with chitosan–alginate microcapsule containing probiotic expressing spring viremia of carp virus (SVCV) G protein provides effective protection against SVCV infection. *Fish Shellfish Immunol.* **2020**, *105*, 327–329. [CrossRef] [PubMed]

138. Cui, L.-C.; Guan, X.-T.; Liu, Z.-M.; Tian, C.-Y.; Xu, Y.-G. Recombinant *lactobacillus* expressing G protein of spring viremia of carp virus (SVCV) combined with ORF81 protein of koi herpesvirus (KHV): A promising way to induce protective immunity against SVCV and KHV infection in cyprinid fish via oral vaccination. *Vaccine* **2015**, *33*, 3092–3099. [CrossRef] [PubMed]

139. Zhang, C.; Guo, S.; Zhao, Z.; Guo, Z.-R.; Ma, R.; Wang, G.-X.; Zhu, B. Surface display of spring viremia of carp virus glycoprotein on *Lactococcus lactis* and its protection efficacy in common carp (*Cyprinus carpio* L.). *Fish Shellfish Immunol.* **2020**, *104*, 262–268. [CrossRef] [PubMed]

140. Lin-Zhao, Z.; Tong-Yang, B.; Yi-Xuan, Y.; Ning-Guo, S.; Xing-Zhang, D.; Nan-Ji, S.; Lv, B.; Huan-Kang, Y.; Feng-Shan, X.; Mei-Shi, Q.; et al. Construction and immune efficacy of recombinant *Lactobacillus casei* expressing OmpAI of *Aeromonas veronii* C5-I as molecular adjuvant. *Microb. Pathog.* **2021**, *156*, 104827. [CrossRef]

141. Li, H.-J.; Yang, B.-T.; Sun, Y.-F.; Zhao, T.; Hao, Z.-P.; Gu, W.; Sun, M.-X.; Cong, W.; Kang, Y.-H. Oral vaccination with recombinant *Lactobacillus casei* with surface displayed OmpK fused to CTB as an adjuvant against *Vibrio mimicus* infection in *Carassius auratus*. *Fish Shellfish Immunol.* **2023**, *135*, 108659. [CrossRef]

142. Yang, Q.; Yang, B.-T.; Kang, Y.-H.; Cong, W. Efficacy of a recombinant *Lactobacillus plantarum* Lp-pPG-Malt as an oral vaccine candidate against *Aeromonas hydrophila* infection in crucian carp. *Fish Shellfish Immunol.* **2023**, *136*, 108737. [CrossRef]

143. Cai, Y.-Z.; Liu, Z.-G.; Lu, M.-X.; Ke, X.-L.; Zhang, D.-F.; Gao, F.-Y.; Cao, J.-M.; Wang, M.; Yi, M.-M. Oral immunization with surface immunogenic protein from *Streptococcus agalactiae* expressed in *Lactococcus lactis* induces protective immune responses of tilapia (*Oreochromis niloticus*). *Aquac. Rep.* **2020**, *18*, 100538. [CrossRef]

144. Yao, J.-Y.; Yuan, X.-M.; Xu, Y.; Yin, W.-L.; Lin, L.-Y.; Pan, X.-Y.; Yang, G.-L.; Wang, C.-F.; Shen, J.-Y. Live recombinant *Lactococcus lactis* vaccine expressing immobilization antigen (i-Ag) for protection against *Ichthyophthirius multifiliis* in goldfish. *Fish Shellfish Immunol.* **2016**, *58*, 302–308. [CrossRef] [PubMed]

145. Santibañez, A.; Paine, D.; Parra, M.; Muñoz, C.; Valdes, N.; Zapata, C.; Vargas, R.; Gonzalez, A.; Tello, M. Oral Administration of *Lactococcus lactis* Producing Interferon Type II, Enhances the Immune Response Against Bacterial Pathogens in Rainbow Trout. *Front. Immunol.* **2021**, *12*, 696803. [CrossRef] [PubMed]

146. Muñoz, C.; González-Lorca, J.; Parra, M.; Soto, S.; Valdes, N.; Sandino, A.M.; Vargas, R.; González, A.; Tello, M. Lactococcus lactis Expressing Type I Interferon From Atlantic Salmon Enhances the Innate Antiviral Immune Response In Vivo and In Vitro. *Front. Immunol.* **2021**, *12*, 696781. [CrossRef] [PubMed]

147. Nakharuthai, C.; Boonanuntanasarn, S.; Kaewda, J.; Manassila, P. Isolation of Potential Probiotic *Bacillus* spp. from the Intestine of Nile Tilapia to Construct Recombinant Probiotic Expressing CC Chemokine and Its Effectiveness on Innate Immune Responses in Nile Tilapia. *Animals* **2023**, *13*, 986. [CrossRef]

148. Zhang, F.-L.; Yang, Y.-L.; Zhang, Z.; Yao, Y.-Y.; Xia, R.; Gao, C.-C.; Du, D.-D.; Hu, J.; Ran, C.; Liu, Z.; et al. Surface-Displayed Amuc_1100 From *Akkermansia muciniphila* on *Lactococcus lactis* ZHY1 Improves Hepatic Steatosis and Intestinal Health in High-Fat-Fed Zebrafish. *Front. Nutr.* **2021**, *8*, 726108. [CrossRef] [PubMed]

149. Yao, Y.-Y.; Xia, R.; Yang, Y.-L.; Hao, Q.; Ran, C.; Zhang, Z.; Zhou, Z.-G. Study about the combination strategy of *Bacillus subtilis* wt55 with AiiO-AIO6 to improve the resistance of zebrafish to *Aeromonas veronii* infection. *Fish Shellfish Immunol.* **2022**, *128*, 447–454. [CrossRef] [PubMed]
130. Naderi-Samani, M.; Soltani, M.; Dadar, M.; Taheri-Mirghaed, A.; Zargar, A.; Ahmadivand, S.; Hassanzadeh, R.; Goudarzi, L.M. Oral immunization of trout fry with recombinant *Lactococcus lactis* NZ3900 expressing G gene of viral hemorrhagic septicaemia virus (VHSV). *Fish Shellfish Immunol.* **2020**, *105*, 62–70. [CrossRef] [PubMed]

131. Zhao, L.; Tang, X.; Sheng, X.; Xing, J.; Zhan, W. Surface display of hirame novirhabdovirus (HIRRV) G protein in *Lactococcus lactis* and its immune protection in flounder (*Paralichthys olivaceus*). *Microb. Cell Factories* **2019**, *18*, 142. [CrossRef]

132. Zhang, L.; Li, Z.; Li, Y.; Tian, J.; Jia, K.; Zhang, D.; Song, M.; Raza, S.H.A.; Garcia, M.; Kang, Y.; et al. OmpW expressed by recombinant *Lactobacillus casei* elicits protective immunity against *Aeromonas veronii* in common carp. *Microb. Pathog.* **2019**, *133*, 103552–103559. [CrossRef]

133. Zhang, D.-X.; Kang, Y.-H.; Chen, L.; Siddiqui, S.A.; Wang, C.-F.; Qian, A.-D.; Shan, X.-F. Oral immunization with recombinant *Lactobacillus casei* expressing OmpAI confers protection against *Aeromonas veronii* challenge in common carp, *Cyprinus carpio*. *Fish Shellfish Immunol.* **2018**, *72*, 552–563. [CrossRef]

134. Chen, C.; Zu, S.; Zhang, D.; Zhao, Z.; Ji, Y.; Xi, H.; Shan, X.; Qian, A.; Han, W.; Gu, J. Oral vaccination with recombinant *Lactobacillus casei* expressing Aha1 fused with CTB as an adjuvant against *Aeromonas veronii* in common carp (*Cyprinus carpio*). *Microb. Cell Factories* **2022**, *21*, 114. [CrossRef] [PubMed]

135. Jiao, X.; Zhang, D.-X.; Chen, C.; Kong, L.-C.; Hu, X.-Y.; Shan, X.-F.; Qian, A.-D. Immunization effect of recombinant *Lactobacillus casei* displaying *Aeromonas veronii* Aha1 with an LTB adjuvant in carp. *Fish Shellfish Immunol.* **2023**, *135*, 108660. [CrossRef] [PubMed]

136. Zhao, Z.; Wang, H.; Zhang, D.; Guan, Y.; Siddiqui, S.A.; Feng-Shan, X.; Cong, B. Oral vaccination with recombinant *Lactobacillus casei* expressing *Aeromonas hydrophila* Aha1 against *A. hydrophila* infections in common carps. *Virulence* **2022**, *13*, 794–807. [CrossRef] [PubMed]

137. Jia, S.; Zhou, K.; Pan, R.; Wei, J.; Liu, Z.; Xu, Y. Oral immunization of carps with chitosan–alginate microcapsule containing probiotic expressing spring viremia of carp virus (SVCV) G protein provides effective protection against SVCV infection. *Fish Shellfish Immunol.* **2020**, *105*, 327–329. [CrossRef] [PubMed]

138. Cui, L.-C.; Guan, X.-T.; Liu, Z.-M.; Tian, C.-Y.; Xu, Y.-G. Recombinant *lactobacillus* expressing G protein of spring viremia of carp virus (SVCV) combined with ORF81 protein of koi herpesvirus (KHV): A promising way to induce protective immunity against SVCV and KHV infection in cyprinid fish via oral vaccination. *Vaccine* **2015**, *33*, 3092–3099. [CrossRef] [PubMed]

139. Zhang, C.; Guo, S.; Zhao, Z.; Guo, Z.-R.; Ma, R.; Wang, G.-X.; Zhu, B. Surface display of spring viremia of carp virus glycoprotein on *Lactococcus lactis* and its protection efficacy in common carp (*Cyprinus carpio* L.). *Fish Shellfish Immunol.* **2020**, *104*, 262–268. [CrossRef] [PubMed]

140. Lin-Zhao, Z.; Tong-Yang, B.; Yi-Xuan, Y.; Ning-Guo, S.; Xing-Zhang, D.; Nan-Ji, S.; Lv, B.; Huan-Kang, Y.; Feng-Shan, X.; Mei-Shi, Q.; et al. Construction and immune efficacy of recombinant *Lactobacillus casei* expressing OmpAI of *Aeromonas veronii* C5-I as molecular adjuvant. *Microb. Pathog.* **2021**, *156*, 104827. [CrossRef]

141. Li, H.-J.; Yang, B.-T.; Sun, Y.-F.; Zhao, T.; Hao, Z.-P.; Gu, W.; Sun, M.-X.; Cong, W.; Kang, Y.-H. Oral vaccination with recombinant *Lactobacillus casei* with surface displayed OmpK fused to CTB as an adjuvant against *Vibrio mimicus* infection in *Carassius auratus*. *Fish Shellfish Immunol.* **2023**, *135*, 108659. [CrossRef]

142. Yang, Q.; Yang, B.-T.; Kang, Y.-H.; Cong, W. Efficacy of a recombinant *Lactobacillus plantarum* Lp-pPG-Malt as an oral vaccine candidate against *Aeromonas hydrophila* infection in crucian carp. *Fish Shellfish Immunol.* **2023**, *136*, 108737. [CrossRef]

143. Cai, Y.-Z.; Liu, Z.-G.; Lu, M.-X.; Ke, X.-L.; Zhang, D.-F.; Gao, F.-Y.; Cao, J.-M.; Wang, M.; Yi, M.-M. Oral immunization with surface immunogenic protein from *Streptococcus agalactiae* expressed in *Lactococcus lactis* induces protective immune responses of tilapia (*Oreochromis niloticus*). *Aquac. Rep.* **2020**, *18*, 100538. [CrossRef]

144. Yao, J.-Y.; Yuan, X.-M.; Xu, Y.; Yin, W.-L.; Lin, L.-Y.; Pan, X.-Y.; Yang, G.-L.; Wang, C.-F.; Shen, J.-Y. Live recombinant *Lactococcus lactis* vaccine expressing immobilization antigen (i-Ag) for protection against *Ichthyophthirius multifiliis* in goldfish. *Fish Shellfish Immunol.* **2016**, *58*, 302–308. [CrossRef] [PubMed]

145. Santibañez, A.; Paine, D.; Parra, M.; Muñoz, C.; Valdes, N.; Zapata, C.; Vargas, R.; Gonzalez, A.; Tello, M. Oral Administration of *Lactococcus lactis* Producing Interferon Type II, Enhances the Immune Response Against Bacterial Pathogens in Rainbow Trout. *Front. Immunol.* **2021**, *12*, 696803. [CrossRef] [PubMed]

146. Muñoz, C.; González-Lorca, J.; Parra, M.; Soto, S.; Valdes, N.; Sandino, A.M.; Vargas, R.; González, A.; Tello, M. Lactococcus lactis Expressing Type I Interferon From Atlantic Salmon Enhances the Innate Antiviral Immune Response In Vivo and In Vitro. *Front. Immunol.* **2021**, *12*, 696781. [CrossRef] [PubMed]

147. Nakharuthai, C.; Boonanuntanasarn, S.; Kaewda, J.; Manassila, P. Isolation of Potential Probiotic *Bacillus* spp. from the Intestine of Nile Tilapia to Construct Recombinant Probiotic Expressing CC Chemokine and Its Effectiveness on Innate Immune Responses in Nile Tilapia. *Animals* **2023**, *13*, 986. [CrossRef]

148. Zhang, F.-L.; Yang, Y.-L.; Zhang, Z.; Yao, Y.-Y.; Xia, R.; Gao, C.-C.; Du, D.-D.; Hu, J.; Ran, C.; Liu, Z.; et al. Surface-Displayed Amuc_1100 From *Akkermansia muciniphila* on *Lactococcus lactis* ZHY1 Improves Hepatic Steatosis and Intestinal Health in High-Fat-Fed Zebrafish. *Front. Nutr.* **2021**, *8*, 726108. [CrossRef] [PubMed]

149. Yao, Y.-Y.; Xia, R.; Yang, Y.-L.; Hao, Q.; Ran, C.; Zhang, Z.; Zhou, Z.-G. Study about the combination strategy of *Bacillus subtilis* wt55 with AiiO-AIO6 to improve the resistance of zebrafish to *Aeromonas veronii* infection. *Fish Shellfish Immunol.* **2022**, *128*, 447–454. [CrossRef] [PubMed]
150. Rupa, P.; Monedero, V.; Wilkie, B.N. Expression of bioactive porcine interferon-gamma by recombinant *Lactococcus lactis*. *Vet. Microbiol.* **2008**, *129*, 197–202. [CrossRef] [PubMed]

151. Jaramillo-Torres, A.; Rawling, M.D.; Rodiles, A.; Mikalsen, H.E.; Johansen, L.-H.; Tinsley, J.; Forberg, T.; Aasum, E.; Castex, M.; Merrifield, D.L. Influence of dietary supplementation of probiotic *Pediococcus acidilactici* MA18/5M during the transition from freshwater to seawater on intestinal health and microbiota of Atlantic salmon (*Salmo salar* L.). *Front. Microbiol.* **2019**, *10*, 2243. [CrossRef]

152. Tello, M. *Application of Metagenomics to Chilean Aquaculture*; IntechOpen: London, UK, 2020; ISBN 9781838800550.

153. (FEEDAP), E.P. on A. and P. or S. used in A.F. Scientific Opinion on the efficacy of Bactocell (*Pediococcus acidilactici*) when used as a feed additive for fish. *EFSA J. 2012*, *10*, 2886. [CrossRef]

154. de Ruyter, P.G.; Kuipers, O.P.; de Vos, W.M. Controlled gene expression systems for *Lactococcus lactis* with the food-grade inducer nisin. *Appl. Environ. Microbiol.* **1996**, *62*, 3662–3667. [CrossRef]

155. Ahn, Y.-J.; Im, E. Heterologous expression of heat shock proteins confers stress tolerance in *Escherichia coli*, an industrial cell factory: A short review. *Biocatal. Agric. Biotechnol.* **2020**, *29*, 101833. [CrossRef]

156. Weidmann, S.; Maitre, M.; Laurent, J.; Coucheney, F.; Rieu, A.; Guzzo, J. Production of the small heat shock protein Lo18 from *Oenococcus oeni* in *Lactococcus lactis* improves its stress tolerance. *Int. J. Food Microbiol.* **2017**, *247*, 18–23. [CrossRef]

**Disclaimer/Publisher's Note:** The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
150. Rupa, P.; Monedero, V.; Wilkie, B.N. Expression of bioactive porcine interferon-gamma by recombinant *Lactococcus lactis*. *Vet. Microbiol.* **2008**, *129*, 197–202. [CrossRef] [PubMed]

151. Jaramillo-Torres, A.; Rawling, M.D.; Rodiles, A.; Mikalsen, H.E.; Johansen, L.-H.; Tinsley, J.; Forberg, T.; Aasum, E.; Castex, M.; Merrifield, D.L. Influence of dietary supplementation of probiotic *Pediococcus acidilactici* MA18/5M during the transition from freshwater to seawater on intestinal health and microbiota of Atlantic salmon (*Salmo salar* L.). *Front. Microbiol.* **2019**, *10*, 2243. [CrossRef]

152. Tello, M. *Application of Metagenomics to Chilean Aquaculture*; IntechOpen: London, UK, 2020; ISBN 9781838800550.

153. (FEEDAP), E.P. on A. and P. or S. used in A.F. Scientific Opinion on the efficacy of Bactocell (*Pediococcus acidilactici*) when used as a feed additive for fish. *EFSA J. 2012*, *10*, 2886. [CrossRef]

154. de Ruyter, P.G.; Kuipers, O.P.; de Vos, W.M. Controlled gene expression systems for *Lactococcus lactis* with the food-grade inducer nisin. *Appl. Environ. Microbiol.* **1996**, *62*, 3662–3667. [CrossRef]

155. Ahn, Y.-J.; Im, E. Heterologous expression of heat shock proteins confers stress tolerance in *Escherichia coli*, an industrial cell factory: A short review. *Biocatal. Agric. Biotechnol.* **2020**, *29*, 101833. [CrossRef]

156. Weidmann, S.; Maitre, M.; Laurent, J.; Coucheney, F.; Rieu, A.; Guzzo, J. Production of the small heat shock protein Lo18 from *Oenococcus oeni* in *Lactococcus lactis* improves its stress tolerance. *Int. J. Food Microbiol.* **2017**, *247*, 18–23. [CrossRef]

**Disclaimer/Publisher's Note:** The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.